Since Brexit, Covid and MHRA world’s first approval of Pfizer Covid vaccine, the FDA is on an exponential curve of falling behind MHRA. That curve will only accelerate. GB is mean and lean for biotech. FDA is fat and always changing leadership. Anyway, that’s the argument against your position. Some would argue your over confidence and that of serious players is only making it easier for MHRA to beat the FDA, because the FDA will remain bogged down in bureaucracy and special interests — mostly the latter — whilst not taking global competition seriously.
Market Data 
Markets 
AI
